|
Sulfatide
|
DB04780 |
[Any of a class of cerebroside sulfuric esters, they are found largely in the medullated nerve fibers and may accumulate in metachromatic leukodystrophy.] |
|
alpha-Arbutin
|
DB14109 |
|
|
Navoximod
|
DB15439 |
[Navoximod is under investigation in clinical trial NCT02048709 (Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors).] |
|
1,2-Hexanediol
|
DB14108 |
|
|
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
|
DB14105 |
|
|
Glucoraphanin
|
DB15436 |
[Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]).] |
|
Linoleic acid
|
DB14104 |
|
|
BMS-986158
|
DB15435 |
[BMS-986158 is under investigation in clinical trial NCT02419417 (Study of BMS-986158 in Subjects With Select Advanced Cancers).] |
|
7-Aminodesacetoxycephalosporanic acid
|
DB14107 |
|
|
Artemin
|
DB15438 |
[Artemin is under investigation in clinical trial NCT01842126 (Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)).] |
|
Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate
|
DB14106 |
|
|
Rocacetrapib
|
DB15437 |
[Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).] |
|
Pinatuzumab vedotin
|
DB15432 |
[Pinatuzumab vedotin is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)).] |
|
Soy isoflavones
|
DB14101 |
|
|
Pork Collagen
|
DB14100 |
[Pork Collagen is used within MACI® (autologous cultured chondrocytes on porcine collagen membrane) as an autologous cellularized scaffold product indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults. It serves as an alternative repair treatment for patients with inadequate response to pre-existing surgical methods. The surgical implantation shows a tolerable safety profile and efficacy up to 4 years, but it is not indicated for patients with osteoarthritis. It has been used since 1995 as Carticel and gained biologic license in 1997. The surgical implantation was first performed in Sweden.] |
|
M-2698
|
DB15431 |
[M-2698 is under investigation in clinical trial NCT01971515 (First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies).] |
|
Methionine sulfoximine
|
DB14103 |
|
|
Mosunetuzumab
|
DB15434 |
[Mosunetuzumab is under investigation in clinical trial NCT03677154 (A Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Therapy in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma Who Are Unable to Tolerate Full-Dose Chemotherapy).] |
|
AVI-7537
|
DB15433 |
[AVI-7537 is under investigation in clinical trial NCT01593072 (A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers).] |
|
Triethylhexanoin
|
DB14102 |
|
